Method
How every lot
gets released.
Four stages, no exceptions. A lot that fails at any stage is quarantined and never enters stock.
Intake and quarantine
Material arrives sealed and is held in quarantine. Nothing is unpacked into stock before a certificate exists.
Independent assay
A sample goes to a third-party laboratory. Identity by mass spectrometry, purity by HPLC, plus endotoxin and moisture.
Review against specification
Results are checked against the published limits. Anything outside specification is rejected — not re-tested until it passes.
Release and publication
The lot enters stock and its certificate goes online, indexed by the lot number printed on the vial.
Specification limits
- Purity (HPLC)
- ≥ 98.0%
- Identity (MS)
- Conforms
- Endotoxin
- ≤ 0.5 EU/mg
- Moisture (KF)
- ≤ 8.0%
- Appearance
- White lyophilised cake
- Retest interval
- 24 months
Record
Twelve months of releases.
| Lot | Compound | Assayed | Purity | Outcome |
|---|---|---|---|---|
| 4471-A | BPC-157 | 2026-07-28 | 99.1% | Released |
| 4470-B | NAD+ | 2026-07-24 | 98.4% | Released |
| 4469-D | Ipamorelin | 2026-07-21 | 96.2% | Rejected |
| 4468-C | TB-500 | 2026-07-19 | 99.4% | Released |
Rejected lots are listed permanently · Placeholder data